Table 2.

Use of antibiotics before (PRE) and after (POST) PHIG intervention. Unit 4 did not participate in data collection after intervention.

	Unit 1		Unit 2		Unit 3 (BMT)		Unit 4		Unit 5		Unit 6		TOTAL		Pediatric hospitals		General hospitals
	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post
Patients	169	186	187	256	103	160	116		173	262	100	126	848	990	579	678	269	312
Antibiotic days	2030	2446	4135	6238	4349	5181	7539		1093	1291	1528	2201	20674	17358	17116	12710	3558	4647
Patient days	4253	5775	6832	11929	4450	5310	18019		2920	5407	3485	6255	39959	34677	32221	22646	7738	12030
LOT/ 1,000 patient days	477	424	605	523	977	976	418		374	239	438	352	517	501	531	561	460	386
DOT/LOT ratio	2.6	2.8	2.1	1.7	1.5	1.5	1.6		2.1	2.2	2.2	1.3	2.0	2.0	1.9	1.9	2.4	2.2
Most commonly used antibiotics - % of DOTS as recorded during first 7 days of treatment
Amik/Genta	27.7	28.1	14.6	9.6	6.5	3.5	22.6		26.4	28.8	24.4	19.4	21.7	20.2	18.6	16.6	26.6	25.9
Cefepime	0.1	0.0	0.5	0.6	0.4	0.4	0.0		25.5	20.9	6.9	6.4	6.1	6.5	8.4	9.5	2.4	1.6
Ceftr/Cefotax	7.6	3.6	3.0	8.9	2.5	1.0	9.8		2.8	1.4	3.3	6.4	5.0	4.0	4.2	3.8	6.2	4.3
Ceftazidime	18.9	0.0	0.0	0.0	0.6	1.5	0.4		0.0	0.0	19.0	4.5	7.3	0.6	0.2	0.4	19.0	1.1
Cipro/Levo	1.3	1.5	0.6	0.5	1.5	10.1	0		1.8	0.5	0.9	0.6	1.1	2.1	1.0	2.7	1.2	1.3
Colistin	0.7	2.3	0.3	0.0	1.5	0.5	0.4		0.0	0.0	0.2	0.5	0.4	0.8	0.4	0.1	0.5	1.8
Meropenem	4.7	4.5	5.4	4.4	6.4	7.9	1.3		4.0	3.9	7.8	13.8	4.8	5.7	4.3	5.0	5.7	6.8
Metronidazole	4.2	4.2	4.1	1.3	1.2	4.7	2.3		1.5	1.2	3.2	8.4	3	3.3	2.4	2.1	3.9	5.3
Pip/Tazo	0.7	24.2	33.3	39.8	52.4	39.7	46.6		9.3	15.4	2.4	37.1	20	28.4	31.5	29.1	1.3	27.4
Vanc/Teico	32.8	30	35.9	30.8	23.2	25.6	10.9		23.9	25.3	25.9	31.7	27	28.4	24.9	30.4%	27.2	30.4

Amik/Genta=Amikacin/Gentamycin; Ceft/Cefotax=Ceftriaxone/Cefotaxime; Cipro/Levo= Ciprofloxacin/ Levofloxacin; Pip/Tazo= Piperacillin/Tazobactam Vanc/Teico=Vancomycin/Teicoplanin.